Alex Sapir

Insider Reports History

Entity
Individual
Location
C/O Dova Pharmaceuticals, Inc., 240 Leigh Farm Road, Suite 245, Durham, NC
Signature
/s/ Greg Tourangeau as attorney-in-fact for Alex Sapir
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alex Sapir:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. President & Chief Executive Officer, Director Common Stock 193K $1.5M $7.76 Jul 3, 2024 Direct
Fulcrum Therapeutics, Inc. President & Chief Executive Officer, Director Stock option - Right to Buy 2.28M Jul 3, 2024 Direct
PhaseBio Pharmaceuticals Inc Director Common Stock 3.75K May 19, 2023 Direct
PhaseBio Pharmaceuticals Inc Director Restricted Stock Units 0 May 19, 2023 Direct

Insider Reports Filed by Alex Sapir

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FULC Fulcrum Therapeutics, Inc. Jul 3, 2024 2 $491K 4 Jul 8, 2024 President & Chief Executive Officer, Director
FULC Fulcrum Therapeutics, Inc. Mar 4, 2024 1 $492K 4 Mar 5, 2024 President & Chief Executive Officer, Director
FULC Fulcrum Therapeutics, Inc. Jul 1, 2023 0 $0 3 Jul 3, 2023 President & Chief Executive Officer Exhibit Index: 24.1 Power of Attorney, Director
PHASQ PhaseBio Pharmaceuticals Inc May 19, 2023 2 $0 4 May 19, 2023 Director
PHASQ PhaseBio Pharmaceuticals Inc May 19, 2022 2 $0 4 May 20, 2022 Director
PHASQ PhaseBio Pharmaceuticals Inc Jun 3, 2021 1 $0 4 Jun 4, 2021 Director